Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ted Yednock
11 Jun 2026
EVP & Chief Innovation Officer
Exercised, kept
30,646
$1.85
$56.70K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 336,896
History held since 24 Jul 2020